Tanke Biosciences Return on Equity (ROE) Growth & History (TNBI)

Tanke Biosciences's return on equity was −1.33% for fiscal 2012.

View full Tanke Biosciences company overview

Tanke Biosciences annual return on equity history

Tanke Biosciences annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20122012-12-31−1.33%+24.78 pp
20112011-12-31−26.11%−63.63 pp
20102010-12-3137.51%

Tanke Biosciences return on equity trends

Between the periods ended 2010-12-31 and 2012-12-31, Tanke Biosciences's return on equity decreased from 37.51% to −1.33%, a change of −38.84 percentage points. The latest reported quarter, Q3 2013, shows −1.93%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Tanke Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about TNBI yet. Start the conversation.

Write the first post